Evaluation of telomerase activity in gingival fibroblasts of cyclosporine-treated patients

被引:1
|
作者
Biray, C. [1 ]
Nizam, N.
Gunduz, C.
Sonmez, S.
Cavdar, C.
Saglam, F.
Atilla, K.
Camsari, T.
机构
[1] Ege Univ, Sch Med, Dept Med Biol, TR-35100 Izmir, Turkey
关键词
D O I
10.1016/j.transproceed.2007.11.065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gingival overgrowth (GO) is a common side effect following administration of cyclosporin A (CsA). Various case reports have shown that squamous cell carcinomas could arise in GO induced by CsA and phenytoin. It is also known that human telomerase activated in about 90% of cancers is mainly composed of hTR, hTERT, and TPI. The aim of this study was to investigate the potential role of telomerase activity in the pathogenesis of CsA-induced GO. Included in the study were 9 patients on CsA: 4 with and 5 without GO. Gingival tissues were obtained during gingivectomy or flap procedures; gingival fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10,000 U/mL penicillin, 10 mg/mL streptomycin, 2 mmol/L L-glutamine, and 10% heat-inactivated fetal bovine serum at 37 degrees C under a humidified 95% air virgule 5% CO2 atmosphere. Quantitative detection of hTERT mRNA was performed with the commercially available LightCycler Telo TAGGG hTERT Quantification Kit using real-time online PCR. The hTERT mRNA expression was positive in one patient, while hTERT mRNA expression was negative in the others. Because results indicated that there may be a relationship between CsA-induced GO and positive telomerase activity, detailed studies should be performed to confirm the present findings.
引用
收藏
页码:184 / 185
页数:2
相关论文
共 50 条
  • [1] Do MMP-1 levels of gingival fibroblasts have a role in the gingival overgrowth of cyclosporine-treated patients?
    Sonmez, S.
    Cavdar, C.
    Gunduz, C.
    Nizam, N.
    Biray, C.
    Atila, K.
    Camsari, T.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (01) : 181 - 183
  • [2] IMMUNOLOGICAL MONITORING IN CYCLOSPORINE-TREATED PATIENTS
    MCKENNA, RM
    SCHROEDER, TJ
    CLINICAL BIOCHEMISTRY, 1991, 24 (01) : 75 - 80
  • [3] PAPILLOMA DEVELOPMENT IN CYCLOSPORINE-TREATED PATIENTS
    VALICENTI, JMK
    PAKULA, A
    CARO, WA
    MALKINSON, FD
    ARCHIVES OF DERMATOLOGY, 1993, 129 (06) : 794 - 795
  • [4] CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTS
    BATIUK, TD
    PAZDERKA, F
    HALLORAN, PF
    TRANSPLANTATION, 1995, 59 (10) : 1400 - 1404
  • [5] RENAL TUBULAR FUNCTION IN CYCLOSPORINE-TREATED PATIENTS
    PALESTINE, AG
    AUSTIN, HA
    NUSSENBLATT, RB
    AMERICAN JOURNAL OF MEDICINE, 1986, 81 (03): : 419 - 424
  • [6] ALLOREACTIVE PRECURSORS ARE PRESERVED IN CYCLOSPORINE-TREATED PATIENTS
    MANCA, F
    CICCIARELLI, J
    GALTON, J
    CAROZZI, S
    KUNKL, A
    BAROCCI, S
    DESSI, V
    VALENTE, U
    CELADA, F
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (06) : 2717 - 2718
  • [7] Renal retransplantation in cyclosporine-treated patients.
    Pascual, J
    Juárez, GF
    Cano, T
    Marcén, R
    Herruzo, J
    Orofino, L
    Liaño, F
    Burgos, FJ
    Mampaso, F
    Quereda, C
    Ortuño, J
    KIDNEY INTERNATIONAL, 1999, 55 (01) : 372 - 372
  • [8] Cancers in cyclosporine-treated vs azathioprine-treated patients
    Penn, I
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (02) : 876 - 878
  • [9] SERIAL IMMUNE EVALUATION OF CYCLOSPORINE-TREATED AND PLACEBO-TREATED MULTIPLE-SCLEROSIS PATIENTS
    KERMAN, RH
    WOLINSKY, JS
    NATH, A
    SEARS, ES
    JOURNAL OF NEUROIMMUNOLOGY, 1988, 18 (04) : 325 - 331
  • [10] Renal function in cyclosporine-treated pediatric renal transplant recipients in relation to gingival overgrowth
    Wondimu, B
    Berg, U
    Modeer, T
    TRANSPLANTATION, 1997, 64 (01) : 92 - 96